Novo Nordisk ADR (NVO) last year’s performance of 5.51% is a clear signal for an entertaining trading season.
Novo Nordisk ADR (NYSE: NVO) kicked off on Friday, down -3.40% from the previous trading day, before settling in for the closing price of $105.32.